+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

  • PDF Icon

    Report

  • 190 Pages
  • March 2023
  • Region: Germany
  • Renub Research
  • ID: 5758513

Germany Diabetes Market was valued at US$ 21.51 Billion in 2022

Germany Diabetes Market is expected to be USD 30.4 Billion in 2028, registering a CAGR of 5.92% during the forecast period, 2023-2028, according to the publisher. Germany has one of the highest diabetes in the European region. The number of type 2 diabetes people will continue to increase over the next twenty years. The German Diabetes Centre (DDZ) estimates that up to 12 Million people might suffer from metabolic disorders in 2040. The substantial increase in incidence not only of type 2 diabetes in the aging population but also of type 1 diabetes will present significant challenges to the German health system in the coming years. Currently, mortality rates among people with diabetes in Germany are about twice as high as those without diabetes.

Leading manufacturers focuses on technological innovations and developing advanced products to gain a substantial market share. There has been a significant rise in insulin delivery systems technology, ranging from insulin injections to insulin pumps. Technological innovations and advancements offer many conveniences in maintaining blood glucose levels. Therefore, owing to the increasing diabetes prevalence, the German diabetes market is anticipated to witness growth over the upcoming years. As a result Germany Diabetes Market was valued at US$ 21.51 Billion in 2022.

Number of Older Adults with Type 2 Diabetes is Increasing Particularly Rapidly

Diabetes is a major health problem and one of the massive challenges for German healthcare systems. The prevalence of 1 & 2 type diabetes in the German adult population is very high, along with an increasing number of undiagnosed patients. Factors to an unhealthy lifestyle and an aging population, the prevalence of type 2 diabetes are expected to increase more over the upcoming years. High-quality care, including adequate monitoring, active self-management, and control of risk factors, is critical for preventing complications of type 2 diabetes in German patients.

Furthermore, the rate of newly diagnosed Type 1 and 2 diabetes cases is seen to increase, mainly due to obesity, unhealthy diet, and physical inactivity. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic care drugs.

Insulin Pen will create more demand in Germany

Germany Diabetic market is segmented into four parts; Insulin Pen, Continuous Glucose Monitoring (CGM) Device, Self Monitoring Blood Glucose (SMBG) Device, and Insulin Pump. All four insulin delivery devices segment mentioned above are growing year on year. Insulin pen will hold significant market demand in upcoming years. Insulin pens are gaining popularity due to their unique features, such as easy to carry, user-friendly design, and ease of usage. With the rising incidences of diabetic problems, various digital care solutions have been introduced to help people with diabetes.

In recent years, Germany has witnessed an alarming increase in the prevalence of diabetes. Patients with diabetes require many daily corrections to maintain nominal blood glucose levels, such as SMBG and CGM, by monitoring their blood glucose levels. Over the past decade, the utilization of diabetes technology, such as insulin pumps and continuous glucose monitors (CGMs), for the management of pediatric type 1 diabetes has increased in Germany. For instance, In Oct 2022, Mediq, a comprehensive European, announced to acquisition DiaExpert, a diabetes specialist and mail-order company for diabetes supplies in Germany, currently part of the Ypsomed Group.

German Government Initiative

Germany diabetes pandemic emerged quickly enough to challenge health services and was gradually sufficient to give the impression that minor changes would be enough to cope with the rising burden. German law planned to cap out-of-pocket healthcare costs and to cover all medically necessary treatment, including insulin drugs, for the public. As a result, German diabetes patients have some of the lowest out-of-pocket expenses in the world.

Germany diabetes is a significant health problem and one of the astounding challenges for healthcare systems. The growing incidence, prevalence, and progressive nature of the disease have encouraged the development of new drugs to provide additional treatment options for diabetic patients. Many newly launched products, increasing awareness about diabetes among people, and increasing international research collaborations in technology advancement are the main opportunities for the players in the German diabetes drugs market.

Key Players

Some of the prominent market players are B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic,Tandem Diabetes Care.

In April 2022, CamDiab, Abbott, and Ypsomed partnered to develop and market an integrated automated insulin delivery (AID) system, which helps to decrease the burden of people with diabetes. The main focus of this partnership will be on European countries.

In June 2022, Abbott announced that it was developing a new bio-wearable for continuously monitoring glucose and ketone levels in one sensor.

This report titled “Germany Diabetes Market, By Self-Monitoring Blood Glucose Device (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP) Companies (B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic and Tandem Diabetes Care)” provides a complete analysis of Germany Insulin Devices Market.

Segments Market based on Devices

1. Continuous Glucose Monitoring (CGM)
2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump

Germany Diabetes Sub-Segment Analysis

1. Continuous Glucose Monitoring (CGM)

1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement

2. SMBG

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement

3. Insulin Pen Market

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies

4. Insulin Pump Market

1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies

All the 13 Companies Studied in the Report have been Studied from 3 Points

  • Company Overview
  • Recent Developments
  • Financial Insight

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly, and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nordisk
6. Ypsomed AG
7. Medtronic
8. Insulet Corporation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Frequently Asked Questions about the German Diabetes Market

What is the estimated value of the German Diabetes Market?

The German Diabetes Market was estimated to be valued at $21.51 Billion in 2022.

What is the growth rate of the German Diabetes Market?

The growth rate of the German Diabetes Market is 5.9%, with an estimated value of $30.38 Billion by 2028.

What is the forecasted size of the German Diabetes Market?

The German Diabetes Market is estimated to be worth $30.38 Billion by 2028.

Who are the key companies in the German Diabetes Market?

Key companies in the German Diabetes Market include B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories and DarioHealth Crop.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Germany Diabetes Market

6. Germany Diabetes Population
6.1 Type 1 Diabetes Population
6.1 Type 2 Diabetes Population

7. Market Share -Germany Diabetes Market
7.1 By Types

8. Continuous Glucose Monitoring Market (CGM) - Germany Market & Users
8.1 Germany- CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Germany- CGM User
8.3 CGM Reimbursement in Germany

9. Blood Glucose Device (SMBG) - Germany Market & Users
9.1 SMBG Market
9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes
9.2 Test Strips Market and Forecast
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market and Forecast
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose Device (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement of Blood Glucose Devices in Germany

10. Insulin Pen - Germany Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen User
10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies

11. Insulin Pump - Germany Market & User Analysis
11.1 Insulin Pump Market
11.1.1 Type 1
11.1.1 Type 2
11.2 Insulin Pump User
11.2.1 Type 1
11.2.1 Type 2
11.3 Differentiation Points of Insulin Pump Products in Germany
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies on Insulin Pump

12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Initiatives & Recent Developments
12.3.3 Revenue
12.4 Becton, Dickinson (BD)
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Initiatives & Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue

13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue

14. SMBG - Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Revenue

15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue

List of Figures:
Figure 01: Germany - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Germany - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Germany - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Germany - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Germany - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Germany - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Germany - Glucose Sensor Market Market (Million US$), 2017 - 2023
Figure 08: Germany - Forecast for Glucose Sensor Market Market (Million US$), 2023 - 2028
Figure 09: Germany - CGM Transmitter Market Market (Million US$), 2017 - 2023
Figure 10: Germany - Forecast for CGM Transmitter Market Market (Million US$), 2023 - 2028
Figure 11: Germany - CGM User (Thousand), 2017 - 2023
Figure 12: Germany - Forecast for CGM User (Thousand),2023 - 2028
Figure 13: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Germany - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Germany - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Germany - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Germany - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Germany - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Germany - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Germany - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Germany - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Germany - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Germany - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Germany - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Germany - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Germany - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Germany - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Germany - Disposable Insulin Pen Market (Million US$), 2017 - 2023
Figure 34: Germany - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
Figure 35: Germany - Reusable Insulin Pen Market (Million US$), 2017 - 2023
Figure 36: Germany - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
Figure 37: Germany - Smart Insulin Pen Market (Million US$), 2017 - 2023
Figure 38: Germany - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
Figure 39: Germany - Disposable Insulin Pen User (Thousand), 2017 - 2022
Figure 40: Germany - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
Figure 41: Germany - Reusable Insulin Pen User (Thousand), 2017 - 2022
Figure 42: Germany - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
Figure 43: Germany - Smart Insulin Pen User (Thousand), 2017 - 2022
Figure 44: Germany - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
Figure 45: Germany - Insulin Pen Needle Market (Million US$), 2017 - 2023
Figure 46: Germany - Forecast for Pen Needle Market (Million US$), 2023 - 2028
Figure 47: Germany - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 48: Germany - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 49: Germany - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 50: Germany - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 51: Germany - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 52: Germany - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 53: Germany - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 54: Germany - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 55: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
Figure 56: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 57: Eli Lilly - Global Revenue (Million US$), 2017 - 2022
Figure 58: Eli Lilly - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 59: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 60: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 61: BD - Global Revenue (Billion US$), 2017 - 2022
Figure 62: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 63: Novo Nordisk A/S - Global Revenue (Million US$), 2017 - 2022
Figure 64: Novo Nordisk A/S - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 65: Ypsomed AG - Global Revenue (Million US$), 2017 - 2022
Figure 66: Ypsomed AG - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 67: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 68: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 69: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 70: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 71: DarioHealth Corp - Global Revenue (Million US$), 2017 - 2022
Figure 72: DarioHealth Corp - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 73: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 74: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Dexcom Inc - Global Revenue (Million US$), 2017 - 2022
Figure 76: Dexcom Inc - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 77: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 78: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 79: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
Figure 80: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028

List of Tables:
Table 01: Germany - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Germany - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028

Companies Mentioned

  • B. Braun Melsungen AG
  • Eli Lilly, and Company
  • Terumo Corporation
  • Becton, Dickinson (BD)
  • Novo Nordisk
  • Ypsomed AG
  • Medtronic
  • Insulet Corporation
  • Abbott Laboratories
  • DarioHealth Crop
  • Dexcom, Inc
  • Roche Diagnostic
  • Tandem Diabetes Care

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...